- Walgreens expanding scope of retail pharmacy experience and services heading into fiscal 2014
- On the heels of Q3, Walgreens outlines shift in front-end strategy and pharmacy tailwinds looking forward
- CNNMoney sits down with Walgreens chief to discuss future of health care and what it means for pharmacy
- Bloomberg: Greg Wasson joins thought leaders to discuss the state of health care in the United States
- Walgreens furthers reach into North Carolina with acquisition of Kerr Drug
NEW YORK — Throughout the month of July, customers of Walgreens helped raise more than $4.6 million for the Juvenile Diabetes Research Foundation, a global organization funding Type 1 diabetes research.
"We are grateful to Walgreens for its exceptional support of our mission, and we thank all of its customers for making such a positive impact on our research programs and helping the millions of people affected by Type 1 diabetes," Jeffery Brewer, president and CEO of JDRF, stated. "For more than two decades, Walgreens has been a dedicated corporate participant, and JDRF is pleased to work with a company that is helping to lessen the impact of Type 1 diabetes until we find a cure."
"Walgreens' Way to Well Commitment is dedicated to providing resources that help with the prevention and detection of today's leading diseases," said Jack Cantlin, divisional VP retail clinical services for Walgreens. "We'd like to thank our customers for their contributions and aligned efforts to help people get, stay and live well."
JDRF and Walgreens are teaming up again this fall to give JDRF supporters the chance to support T1D research when they get their flu shots. From Sept. 1 through Oct. 31, Walgreens will donate $1 to JDRF for each flu shot administered when a customer presents the JDRF/Walgreens flyer at checkout. Walgreens has committed a minimum of $25,000 to this program, with a maximum of $100,000.